1. Home
  2. HLIO vs BEAM Comparison

HLIO vs BEAM Comparison

Compare HLIO & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helios Technologies Inc.

HLIO

Helios Technologies Inc.

N/A

Current Price

$70.44

Market Cap

2.6B

Sector

Industrials

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$29.03

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HLIO
BEAM
Founded
1970
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
HLIO
BEAM
Price
$70.44
$29.03
Analyst Decision
Buy
Buy
Analyst Count
6
12
Target Price
$66.17
$50.75
AVG Volume (30 Days)
275.0K
1.6M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
0.72%
N/A
EPS Growth
23.93
82.31
EPS
1.25
N/A
Revenue
$200,727,000.00
$24,000.00
Revenue This Year
$3.67
N/A
Revenue Next Year
$5.00
$33.77
P/E Ratio
$58.42
N/A
Revenue Growth
N/A
33.33
52 Week Low
$47.05
$16.52
52 Week High
$95.05
$38.26

Technical Indicators

Market Signals
Indicator
HLIO
BEAM
Relative Strength Index (RSI) 29.52 52.90
Support Level $63.09 $28.40
Resistance Level $73.24 $31.98
Average True Range (ATR) 2.43 1.41
MACD -0.67 0.29
Stochastic Oscillator 1.09 62.91

Price Performance

Historical Comparison
HLIO
BEAM

About HLIO Helios Technologies Inc.

Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: